Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
MedTech
GE HealthCare to acquire Intelerad for $2.3B
With its focus on radiology and cardiology practices, Intelerad’s outpatient footprint will complement GE HealthCare’s in-hospital imaging business.
Conor Hale
Nov 20, 2025 4:34pm
Cooper Companies under pressure to split—in different ways
Nov 20, 2025 1:47pm
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Nov 20, 2025 10:30am
Why Novartis CEO was willing to pay top dollar for Avidity
Nov 20, 2025 4:37am
JSR hands over Crown to Carlyle-backed company in $204M deal
Nov 18, 2025 2:32pm
Repare nails down XenoTherapeutics buyout
Nov 17, 2025 12:12pm
